|
PRDM10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.997060E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.182200E-04 |
| Normal-vs-Stage2 |
4.058400E-01 |
| Normal-vs-Stage3 |
1.643030E-01 |
| Normal-vs-Stage4 |
1.381990E-01 |
| Stage1-vs-Stage2 |
1.248980E-01 |
| Stage1-vs-Stage3 |
2.653400E-01 |
| Stage1-vs-Stage4 |
5.937600E-01 |
| Stage2-vs-Stage3 |
6.880000E-01 |
| Stage2-vs-Stage4 |
6.155800E-01 |
| Stage3-vs-Stage4 |
8.660000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.502240E-03 |
| Normal-vs-AfricanAmerican |
1.177680E-02 |
| Normal-vs-Asian |
7.033400E-01 |
| Caucasian-vs-AfricanAmerican |
9.387400E-01 |
| Caucasian-vs-Asian |
5.643600E-01 |
| AfricanAmerican-vs-Asian |
5.579200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.773000E-04 |
| Normal-vs-Female |
6.167600E-01 |
| Male-vs-Female |
2.423100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.178010E-02 |
| Normal-vs-Extreme_Weight |
5.80689999999384E-05 |
| Normal-vs-Obese |
8.731600E-02 |
| Normal-vs-Extreme_Obese |
8.938200E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.660000E-01 |
| Normal_Weight-vs-Obese |
2.876800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.015000E-01 |
| Extreme_Weight-vs-Obese |
1.646040E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.895800E-01 |
| Obese-vs-Extreme_Obese |
2.606000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.699200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.816500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.765250E-04 |
| Normal-vs-Age(81-100Yrs) |
1.165280E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.372600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.231900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.543800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.511800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.859600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.612400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.023700E-03 |
| Normal-VS-Type2 PRCC |
8.394100E-04 |
| Normal-VS-KIRP CIMP |
7.036000E-01 |
| Normal-VS-Unclassified PRCC |
3.189200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.373000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.995700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.814550E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.846180E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.502500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.986600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.585560E-04 |
| Normal-vs-N1 |
4.364600E-01 |
| Normal-vs-N2 |
8.318500E-02 |
| N0-vs-N1 |
2.046300E-02 |
| N0-vs-N2 |
9.900800E-01 |
| N1-vs-N2 |
3.425200E-01 |
|
|
